Download PDF
Thromb Haemost 1994; 72(04): 526-533
DOI: 10.1055/s-0038-1648908
Original Article
Schattauer GmbH Stuttgart

Homozygous Type I Protein C Deficiency in Two Unrelated Families Exhibiting Thrombophilia Related to Ala136→Pro or Arg286→His Mutations

G L Long
1   The Department of Biochemistry, School of Medicine, University of Vermont, Burlington VT, USA
,
J A Tomczak
1   The Department of Biochemistry, School of Medicine, University of Vermont, Burlington VT, USA
,
I R Rainville
1   The Department of Biochemistry, School of Medicine, University of Vermont, Burlington VT, USA
,
M Dreyfus
2   The Laboratory of Hematology, Hôpital A. Béclère, Clamart, France
,
W Schramm
3   The Medizinische Klinik Innenstadt, University of Munich, Germany
,
H P Schwarz
4   Immuno AG, Vienna, Austria
› Author Affiliations
Further Information

Publication History

Received 28 March 1994

Accepted after revision 23 June 1994

Publication Date:
06 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

Separate single nucleotide mutations have been identified in two unrelated homozygous type I protein C deficient individuals suffering from thrombophilia. Each mutation, initially established by direct DNA sequencing of polymerase chain reaction amplification products, results in an amino acid substitution. The first mutation (PCClamart) results in an Ala136 to Pro substitution in the protein’s second epidermal growth factor-like domain. The second mutation (PCMtinchen) results in an Arg286 to His substitution in the serine protease domain. Comparison of the location of these two mutations and the relative conservation of the two regions in homologous vitamin K-dependent plasma proteins is consistent with the difference in severity of protein C deficiency and disease in the two individuals. Both mutations result in the abolition of a naturally occurring restriction endonuclease site, thereby allowing independent confirmation of the mutations and rapid and unambiguous genetic analysis of protein C deficiency in family members. In both families, the genetic analysis has proven useful in cases where an assignment of the protein C status based upon clinical laboratory measurements was either ambiguous or incorrect.

 

  • References

  • 1 Marlar RA, Kleiss AJ, Griffin JH. Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme. Blood 1982; 59: 1067-1072
    PubMedGoogle Scholar
  • 2 Clouse LH, Comp PC. The regulation of hemostasis: The protein C system. N Engl J Med 1986; 314: 1298-1304
    CrossrefPubMedGoogle Scholar
  • 3 Seegers W, McCoy LE, Groben HD, Sakuragawa N, Agrawal BBL. Purification and properties of autoprothrombin II a: An anticoagulant perhaps also related to fibrinolysis. Thromb Res 1972; 1: 43
    PubMedGoogle Scholar
  • 4 Comp PC, Esmon CT. Generation of fibrinolytic activity by infusion of activated protein C into dogs. J Clin Invest 1981; 68: 1221-1228
    CrossrefPubMedGoogle Scholar
  • 5 Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981; 68: 1370-1373
    CrossrefPubMedGoogle Scholar
  • 6 Marlar RA. Protein C in thromboembolic disease. Semin Thromb Hemost 1985; 11: 387-393
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Bertina RM, Broekmans AW, van der Linden IK, Mertens K. Protein C deficiency in a Dutch family with thrombotic disease. Thromb Haemost 1982; 48: 1-5
    PubMedGoogle Scholar
  • 8 Pabinger-Fasching I, Bertina RM, Lechner K, Niessner H, Kominger CH. Protein C deficiency in two Austrian families. Thromb Haemost 1983; 50: 810-813
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Broekmans AW, Veltkamp JJ, Bertina RM. Congenital protein C deficiency and venous thromboembolism. A study of three Dutch families. N Engl J Med 1983; 309: 340-344
    CrossrefPubMedGoogle Scholar
  • 10 Horellou MH, Conard J, Bertina RM, Samama M. Congenital protein C deficiency and thrombotic disease in nine French families. Brit Med J 1984; 289: 1285-1287
    CrossrefPubMedGoogle Scholar
  • 11 Seligson U, Berger A, Abend M, Rubin L, Attias D, Zivelin A, Rapaport SI. Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med 1984; 310: 559-562
    CrossrefPubMedGoogle Scholar
  • 12 Marlar RA, Montgomery RR, Madden RM. Homozygous protein C deficiency. In: Protein C and Related Proteins Bertina RM. ed. Churchill Livingstone Press; New York NY: 1988: 160-181
  • 13 Miletich J, Sherman L, Broze G. Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 1987; 317: 991-995
    CrossrefPubMedGoogle Scholar
  • 14 Pabinger I, Lechner K. Acquired protein C and protein S deficiency. In: Protein C and Related Proteins Bertina RM. ed. Churchill Livingstone Press; New York NY: 1988: 213-225
  • 15 Pabinger I, Allaart CF, Hermans J, Briët E, Bertina RM. the Protein C Transmitter Study Group. Hereditary protein C-deficiency: laboratory values in transmitters and guidelines for the Diagnostic Procedure Report on a study of the SSC subcommittee on protein C and protein S. Thromb Haemost 1992; 68: 470-474
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Dreyfus M, Magny JF, Bridey F, Schwarz HP, Planche C, Dehan M, Tchernia G. Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate. N Engl J Med 1991; 325: 1565-1568
    CrossrefPubMedGoogle Scholar
  • 17 Schwarz HP, Linnau Y, Schramm W, Dreyfus M, Bauer KA. Treatment of protein C deficiency with a monoclonal antibody purified protein C concentrate. Circulation 1990; 82: 111-134 (Abstr.)
    PubMedGoogle Scholar
  • 18 Schmidel DK, Nelson RM, Broxson EH, Comp PC, Marlar RA, Long GL. A 5.3 Kb deletion including exon XIII of the protein S a gene occurs in two protein S-deficient families. Blood 1991; 77: 551-559
    PubMedGoogle Scholar
  • 19 Bovill EG, Tomczak JA, Grant B, Bhushan F, Pillemer E, Rainville IR, Long GL. Protein CVermont: Symptomatic type II protein C deficiency associated with two GLA domain mutations. Blood 1992; 79: 1456-1465
    PubMedGoogle Scholar
  • 20 Plutzky J, Hoskins JA, Long GL, Crabtree GR. Evolution and organization of the human protein C gene. Proc Natl Acad Sci USA 1986; 83: 546-550
    CrossrefPubMedGoogle Scholar
  • 21 Foster DC, Yoshitake S, Davie EW. The nucleotide sequence of the gene for human protein C. Proc Natl Acad Sci USA 1985; 82: 4673-4677
    CrossrefPubMedGoogle Scholar
  • 22 Beckmann RJ, Schmidt RJ, Santerre RF, Plutzky J, Crabtree GR, Long GL. The structure and evolution of a 461 amino acid human protein C precursor and its messenger RNA, based upon the DNA sequence of cloned human liver cDNAs. Nucleic Acids Res 1985; 13: 5233-5247
    CrossrefPubMedGoogle Scholar
  • 23 Nicham S, Guichaoua JS, Contant G, Martinoli JL. Dosage rapide de l’activité de la protéine C. Ann Biol Clin (Paris) 1988; 46: 805-809
    PubMedGoogle Scholar
  • 24 Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefson DM, Powers P. Development of the human coagulation system in the full-term infant. Blood 1987; 70: 165-172
    CrossrefPubMedGoogle Scholar
  • 25 Long GL. Structure and evolution of the human genes encoding protein C and coagulation factors VII, IX, and X. Cold Spr Harbor Symp Quant Biol 1986; 51: 525-529
    PubMedGoogle Scholar
  • 26 Kurachi K, Davie EW. Isolation and characterization of a cDNA coding for human factor IX. Proc Natl Acad Sci USA 1982; 79: 6461-6464
    CrossrefPubMedGoogle Scholar
  • 27 Leytus SP, Chung DW, Kisiel W, Kurachi K, Davie EW. Characterization of a cDNA coding for human factor X. Proc Natl Acad Sci USA 1984; 81: 3699-3702
    CrossrefPubMedGoogle Scholar
  • 28 Hagen FS, Gray CL, O’Hara P, Grant FJ, Saari GC, Woodbury RG, Hart CE, Insley M, Kisiel W, Kurachi K, Davie EW. Characterization of a cDNA coding for human factor VII. Proc Natl Acad Sci USA 1986; 83: 2412-2416
    CrossrefPubMedGoogle Scholar
  • 29 Degen SJ, MacGillivray RTA, Davie EW. Characterization of the complementary deoxyribonucleic acid and gene coding for human prothrombin. Biochemistry 1983; 22: 2087-2097
    CrossrefPubMedGoogle Scholar
  • 30 Stenflo J. Structure-function relationships of EGF modules in vitamin K-dependent clotting factors. Blood 1991; 78: 1637-1651
    PubMedGoogle Scholar
  • 31 Giannelli F, Green PM, High KA, Sommer S, Lillicrap DP, Ludwig M, Olek K, Reitsma PH, Goossens M, Yoshioka A, Brownlee GG. Haemophilia B: Database of point mutations and short additions and deletions - third edition, 1992. Nucleic Acids Res 1992; (Suppl. 20) 2027-2063
    PubMedGoogle Scholar
  • 32 Seibel P, Degoul F, Romero N, Marsac C, Kadenbach B. Identification of point mutations by mispairing PCR as exemplified in MERRF disease. Bio-chem Biophys Res Commun 1990; 173: 561-565
    CrossrefPubMedGoogle Scholar